A PATIENT IN THE LAB®

HUB Organoids predict patient response to treatment.

Our patented technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.

find out more application

What we can do for you

Drug development

Reduce drug attrition and predict patient response with our preclinical services and clinical trials in a dish
Link

icon-model-development.png

Custom solutions

Decipher the complexity of the human disease with our custom model and assay development services
Link

License HUB Organoid Technology

Licensing program

Bring HUB Organoid Technology and knowhow in-house
Link

We’re already making an impact

by bringing next-generation therapeutics to patients

 
 

Bring HUB Organoid Technology and knowhow in-house

apply for a license

Outsource your drug development program

discover our sevices

Latest news

NEWS & PRESS RELEASE

HUB Organoids Launches IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD) Drug Discovery and Development

read more

NEWS

Tumors in Space Investigates Microgravity’s Impact on Cancer Using Patient-Derived HUB Organoids

read more

BLOG

The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development

read more

X

Have any questions?

contact us
NEW LAUNCH!

IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD)  Drug Discovery and Development

find out more

Powered by